{"id":"W2569660516","doi":"10.1182/blood.v112.11.1560.1560","title":"The Efficacy and Safety of Lenalidomide Oral Monotherapy in Patients with Mantle Cell Lymphoma Previously Treated with Bortezomib: Pooled Data from Two Phase II Studies (NHL-002 and NHL-003).","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lenalidomide; Bortezomib; Medicine; Mantle cell lymphoma; Internal medicine; Thalidomide; Gastroenterology; Regimen; Multiple myeloma; Phases of clinical research; Proteasome inhibitor; Progressive disease; Oncology; Surgery; Lymphoma; Clinical trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002718959,0.0002593622,0.0006015884,0.00008226404,0.0002056853,0.00001753705,0.0002308956,0.00005839824,0.000011244],"category_scores_gemma":[0.0001079805,0.0001450771,0.00001974591,0.0002773943,0.0005027351,0.0001302755,0.0002177661,0.0001095363,0.000001893552],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004041774,"about_ca_system_score_gemma":0.001156355,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001599624,"about_ca_topic_score_gemma":0.0004890387,"domain_scores_codex":[0.9981167,0.0001147401,0.0004043168,0.0005183506,0.0004687147,0.0003771594],"domain_scores_gemma":[0.9982486,0.000417525,0.0001617803,0.0008857243,0.0001481263,0.0001382623],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1585,0.02923047,0.7323937,0.0005950756,0.007595777,0.001690461,0.01274954,0.00003166683,0.002449586,0.00001922928,0.00186499,0.05287951],"study_design_scores_gemma":[0.8566537,0.00478475,0.1269436,0.0004879344,0.0008647918,0.0001039975,0.000430746,0.001221921,0.007670984,0.000009459804,0.0005092699,0.0003189044],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912549,0.007148559,0.000004852275,0.00008210714,0.00001052609,0.001274637,0.0001027024,0.00002625437,0.00009547263],"genre_scores_gemma":[0.9950265,0.004067977,0.0003923168,0.00004811933,0.00004013607,0.00002113896,0.0001607492,0.00004618696,0.000196838],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6981537,"threshold_uncertainty_score":0.5916072,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03076992610339992,"score_gpt":0.3065380049983145,"score_spread":0.2757680788949146,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}